Literature DB >> 3691179

A specific chromosomal abnormality in rhabdomyosarcoma.

E C Douglass1, M Valentine, E Etcubanas, D Parham, B L Webber, P J Houghton, J A Houghton, A A Green.   

Abstract

A specific chromosomal abnormality, t(2;13)(q35;q14), was discovered in five cases of advanced rhabdomyosarcoma. It was identified directly in cells that had metastasized from bone marrow in one patient and in xenografts derived from the tumors of four other patients. The translocation was not restricted by histologic subtype, but was found in cases classified as alveolar, undifferentiated, or embryonal. Cytogenetic hallmarks of gene amplification (double minute chromosomes and homogeneously staining regions) were apparent in three cases. Other frequent abnormalities included rearrangements of chromosomes lp and trisomy of chromosome 8. The absence of the t(2;13) in more than 100 cases of other pediatric solid tumors investigated in our laboratory indicates its specificity for rhabdomyosarcoma. These cytogenetic findings suggest directions for further investigation of the molecular events underlying the genesis of this tumor.

Entities:  

Mesh:

Year:  1987        PMID: 3691179     DOI: 10.1159/000132446

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  74 in total

1.  A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.

Authors:  S Gattenloehner; B Dockhorn-Dworniczak; I Leuschner; A Vincent; H K Müller-Hermelink; A Marx
Journal:  J Mol Diagn       Date:  1999-11       Impact factor: 5.568

2.  A case of alveolar rhabdomyosarcoma with a chromosomal translocation, t(2;13)(q37;q14).

Authors:  T Nojima; S Abe; H Yamaguchi; T Matsuno; K Inoue
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Authors:  Lisa E S Crose; Katherine T Etheridge; Candy Chen; Brian Belyea; Lindsay J Talbot; Rex C Bentley; Corinne M Linardic
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

4.  Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.

Authors:  Doris Phelps; Kathryn Bondra; Star Seum; Christopher Chronowski; Justin Leasure; Raushan T Kurmasheva; Steven Middleton; Dian Wang; Xiaokui Mo; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2015-04-01       Impact factor: 3.167

5.  Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.

Authors:  Myriam Goldstein; Isaac Meller; Josephine Issakov; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

6.  Targeting ALK in pediatric RMS does not induce antitumor activity in vivo.

Authors:  Monika Wierdl; Lyudmila Tsurkan; Liying Chi; M Jason Hatfield; Viktor Tollemar; Cori Bradley; Xiang Chen; Chunxu Qu; Philip M Potter
Journal:  Cancer Chemother Pharmacol       Date:  2018-05-31       Impact factor: 3.333

7.  Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.

Authors:  L Krsková; M Mrhalová; D Sumerauer; R Kodet
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

8.  The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.

Authors:  Khin Thway; Jayson Wang; Dorte Wren; Melissa Dainton; David Gonzalez; John Swansbury; Cyril Fisher
Journal:  Virchows Arch       Date:  2015-04-26       Impact factor: 4.064

9.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.

Authors:  P Thorner; J Squire; S Chilton-MacNeil; P Marrano; J Bayani; D Malkin; M Greenberg; A Lorenzana; M Zielenska
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.